Assessing the painful, uninflamed eye in primary care

We acknowledge the important contributions of Professor Amada J Lee, University of Aberdeen, Division of Statistics, for assistance with analysing the data from the patient survey. We thank Kamran Khan, Oliver Chadwick, and Paul Chua, trainee ophthalmologists, NHS Grampian, for providing the clinical images. Contributors: LK contributed to the design of the study, the survey of patients, and writing the paper. JVF contributed to the design of the study and writing the paper. ADD contributed to the design of the study, the survey of the patients, and writing the paper. JVF is guarantor for the paper.Peer reviewedPublisher PD

Autoimmunity, Autoinflammation, and Infection in Uveitis

Funding/Support: No funding or grant support. Financial Disclosures: John V. Forrester has received an honorarium for lecturing from Janssen (London, UK). Lucia Kuffova has undertaken consultancy work for Abbvie (London, UK). Andrew D. Dick has undertaken consultancy work for Abbvie (London, UK), Roche (London, UK), and Genentech (London, UK) and has received honoraria from Janssen (London, UK) and Abbvie (London, UK). The authors attest that they meet the current ICMJE criteria for authorship.Peer reviewedPublisher PD

Immune Privilege Furnishes a Niche for Latent Infection

FUNDING University of Aberdeen Development Trust/Saving Sight in Grampian: grant number RG16220-10Peer reviewedPublisher PD

Dendritic cells and the extracellular matrix : A challenge for maintaining tolerance/homeostasis

Supported by The Royal College of Surgeons of Edinburgh. ACKNOWLEDGMENTS We would like to thank the Microscopy Core Facility and the Medical Research Facility at the University of Aberdeen for technical assistance. All experiments on animals were performed according to the guidelines described in the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Vision and Ophthalmic Research and Animal License Act (United Kingdom).Peer reviewedPublisher PD

The Role of Inflammation in Diabetic Retinopathy

Funding Information: This paper was financially supported by Ministry of Health and Fondazione Roma. Publisher Copyright: © 2020 Verduci Editore s.r.l. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Peer reviewedPublisher PD

Immune Privilege : the Microbiome and Uveitis

Funding information: Fight for Sight. The ideas developed in this article were derived from work supported by Fight for Sight, The Eye Charity [CSO project grant award: 3031-3032] awarded to HMW, and by The Development Trust of the University of Aberdeen (Saving Sight in Grampian)Peer reviewedPublisher PD

Limbal epithelial stem cell activity and corneal epithelial cell cycle parameters in adult and aging mice

NS was funded by a Ministry of Education in Saudi Arabia PhD studentship. LK was funded by Saving Sight in Grampian, University of Aberdeen Development Trust. This work was performed under University of Aberdeen Development Trust Funding (‘Research into Corneal Blindness’) to JMC, LE and NV and BBSRC Research Grant BB/J015237/1 to JMC.Peer reviewedPublisher PD

The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft induced lymphangiogenesis

Open Access via Springer Compact Agreement Funding: Saving Sight in Grampian provided financial support in the forming of Saving Sight in Grampian funding. The sponsor had no role in the design or conduct of this research.Peer reviewedPublisher PD

A Role for Folate in Microbiome-Linked Control of Autoimmunity

Acknowledgments The ideas developed in this article were derived from work supported by Fight for Sight, The Eye Charity [CSO project grant award: 3031-3032] awarded to HMW and by the Development Trust of the University of Aberdeen (Saving Sight in Grampian) [grant codes: RG-12663 and RG-14251.Peer reviewedPublisher PD

High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection

Acknowledgments The authors thank M. Robertson and R. Fordyce for technical support during the duration of the study. The work performed in Aberdeen was supported by grant from Action Medical Research UK (SP4328; London, England, UK), NHS Grampian Endowment grant (12/49; Aberdeen, Scotland, UK), and Saving Sight in Grampian (Charity No.SC002938; Aberdeen, Scotland, UK). The work performed in Pittsburgh was supported by a Fight for Sight Post-Doctoral Award (JEK; New York, NY, USA); unrestricted grants from the Western Pennsylvania Medical Eye Bank Foundation (Pittsburgh, PA, USA), Research to Prevent Blindness (New York, NY, USA), and the Eye and Ear Foundation of Pittsburgh (RLH; Pittsburgh, PA, USA); and National Institutes of Health Grants P30EY08098 (RLH; Bethesda, MD, USA) and EY10359 (RLH).Peer reviewedPublisher PD